PubMed - Sept 2008 Mondria T, Lamers CH, te Boekhorst PA, Gratama JW, Hintzen RQ.Department of Neurology, Erasmus University Medical School, Erasmus MC, 3000 CA Rotterdam, The Netherlands.BACKGROUND: Given the presumed key role for autoreac... %26raquo; Read More
Mondria T, Lamers CH, te Boekhorst PA, Gratama JW, Hintzen RQ.
Department of Neurology, Erasmus University Medical School, Erasmus MC, 3000 CA Rotterdam, The Netherlands.
BACKGROUND: Given the presumed key role for autoreactive lymphocytes in multiple sclerosis (MS), treatment strategies have been developed to ablate lymphocyte activity. Intrathecal lymphocyte activation can be measured by CSF-soluble(s)CD27.
OBJECTIVE: To determine the effect of maximum whole-body immune ablation on two different markers that detect lymphocyte activation in CSF-oligoclonal IgG bands and levels of CSF-sCD27.
============================================
2/01/2009
Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis
PubMed - Sept 2008
Leaving comments is a great way to get others involved with the topic. Please feel free to leave your comment(s) for any of the postings found on this blog.